Literature DB >> 20941470

[Chronic actinic dermatitis. Therapy with systemic PUVA and mycophenolate mofetil].

V Lichte1, G Metzler, M Röcken, M Schaller, M Berneburg.   

Abstract

A 66-year-old man was diagnosed with psoriasis in 2001 and treated accordingly; in 2007, the diagnosis was switched to atopic dermatitis and the therapy modified. Initially he improved with fumarates and methotrexate, but then experienced recurrent exacerbations with erythroderma and severe superinfection requiring hospitalization. Based on the modified clinical picture with striking accentuation on the head and back of the hands, we diagnosed chronic actinic dermatitis. In September 2008 immunosuppressive therapy with mycophenolate mophetil (2×500 mg/d) was started. Since the response was modest, photo-hardening with systemic photochemotherapy (PUVA) was added, producing close to complete recovery within 6 months.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20941470     DOI: 10.1007/s00105-010-2054-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  6 in total

1.  Mycophenolate in psoralen-UV-A desensitization therapy for chronic actinic dermatitis.

Authors:  H C Nousari; G J Anhalt; W L Morison
Journal:  Arch Dermatol       Date:  1999-09

2.  [Treatment of chronic actinic dermatitis with mycophenolate mofetil].

Authors:  Katarzyna Weidgang; Sandra Diesler; Thomas Krieg; Nicolas Hunzelmann
Journal:  J Dtsch Dermatol Ges       Date:  2005-09       Impact factor: 5.584

Review 3.  [The syndrome of chronic actinic dermatitis. Persistent light reaction--actinic reticuloid].

Authors:  C Wolf; H Hönigsmann
Journal:  Hautarzt       Date:  1988-10       Impact factor: 0.751

4.  [Oral photochemotherapy for actinic reticuloid].

Authors:  T Hunziker; Y Knecht; A Krebs
Journal:  Dermatologica       Date:  1982-08

5.  [PUVA therapy in persistent light reaction].

Authors:  A Galosi; E Hölzle; G Plewig; O Braun-Falco
Journal:  Hautarzt       Date:  1982-12       Impact factor: 0.751

6.  [Chronic actinic dermatitis. Concept and case examples].

Authors:  P Milde; E Hölzle; N Neumann; P Lehmann; U Trautvetter; G Plewig
Journal:  Hautarzt       Date:  1991-10       Impact factor: 0.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.